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Glomerulosclerosis and viral gene expression in HIV-trans- Human immunodeficiency virus-associated nephropa-
genic mice: Role of nef. thy (HIVAN) is a clinical and pathologic syndrome that
Background. Human immunodeficiency virus (HIV)-associ- affects up to 10% of HIV-infected individuals, particu-
ated nephropathy is characterized by focal segmental glomeru-
larly African Americans [1, 2]. Clinically, patients de-losclerosis and microcystic tubular dilation. We have previously
velop nephrotic syndrome and often progress rapidly todescribed a mouse transgenic for a Dgag-pol HIV-1 genome,
which develops glomerulosclerosis, cutaneous papillomas, and end-stage renal disease [3]. Pathologically, HIVAN is cha-
cataracts. racterized by focal segmental glomerulosclerosis (FSGS),
Methods. We developed mice transgenic for a Dgag-pol-nef microcystic tubular dilation, and a mononuclear intersti-
HIV genome in order to investigate the role of the nef gene
tial infiltrate. Particular features that serve to distinguishin these phenotypes.
HIV-associated FSGS from idiopathic FSGS include glo-Results. One transgenic line, X5, expressed HIV mRNA in
merular collapse, swollen and hyperplastic glomerularkidney and consistently manifested focal segmental glomerulo-
sclerosis and tubular dilation by six weeks of age. Northern visceral epithelial cells, tubuloreticular inclusions within
analysis indicated that renal transgene expression was higher glomerular and peritubular capillary endothelial cells,
in the Dgag-pol-nef mice compared with the Dgag-pol mice. and degenerated and necrotic tubular epithelial cells [4].In situ hybridization and immunostaining demonstrated HIV
The pathogenesis of HIVAN remains uncertain. Stud-RNA and protein expression within the glomerular epithelial
ies of in vitro infection suggest that the glomerular endo-cells and tubular epithelial cells. These cell types showed histo-
logic evidence of toxicity, including vacuolation and detach- thelial cell is susceptible to infection, while the glomeru-
ment from basement membrane, and exhibited increased rates lar epithelial cell is resistant to infection [5]. Controversy
of apoptosis. These data suggest that the renal disease seen remains about whether the mesangial cell can be infected
in the Dgag-pol-nef transgenic mouse may be caused by the
in vitro [5, 6]. Proviral DNA can be detected by polymer-expression of HIV genes within renal epithelial cells, that this
ase chain reaction (PCR) within microdissected glomer-expression may induce cellular toxicity, including apoptosis,
uli, tubules, and interstitial fragments obtained fromand that nef is not required for the induction of renal disease.
We have previously described mice bearing the nef gene, which biopsy material of patients with HIVAN [7]. Cohen et
do not manifest renal disease. In further experiments, Dgag- al suggested that HIV-1 p24 Gag antigen was present in
pol-nef mice were bred with nef mice; these dual-transgenic renal tubular epithelial cells from patients with HIVANmice developed renal disease that generally resembled that
[8], but this has remained controversial (Note Added inseen in Dgag-pol-nef mice, but with somewhat more severe
Proof). Similarly, Cohen et al carried out in situ hybrid-glomerulosclerosis and less severe tubulointerstitial injury.
Results. The results of these transgenic studies suggest that ization with DNA probes and found evidence of viral
the role of nef is complex and may act both to reduce transgene nucleic acid within glomerular epithelial cells and tubular
expression and to potentiate glomerular injury induced by epithelial cells [8], but subsequent studies using RNA
other HIV-1 gene products.
probes for in situ hybridization have failed to localize
viral RNA within kidney (abstract; Pardo et al, FASEB
J 15:A907, 1991). It remains unclear whether HIV-1 di-Key words: focal segmental glomerulosclerosis, renal failure, envelope
protein, gp120, apoptosis. rectly infects intrinsic renal cells, resulting in toxicity or
immune recognition, whether the virus infects lympho-Received for publication January 28, 1999
cytes or monocytes within kidney, leading to the releaseand in revised form February 23, 2000
Accepted for publication April 3, 2000 of viral products or cytokines, or whether circulating
viral products or cytokines affect renal cells.Ó 2000 by the International Society of Nephrology
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We have previously shown that transgenic mice bear- in the nef gene (Fig. 1). This construct was microinjected
into FVB/N mouse oocytes. Seven founder mice, all phe-ing a Dgag-pol HIV-1 genome under the control of the
viral long-terminal repeat (LTR) develop focal glomeru- notypically normal, were mated to normal FVB/N mice
to produce the F1 generation. Hemizygous F1 mice, aslosclerosis [11, 12]. These T26 mice do not manifest CD4
depletion and do not develop opportunistic infections determined by Southern blotting, were crossed to pro-
duce litters with homozygous transgenic, hemizygousunder normal laboratory conditions, suggesting that
HIV-1 gene products are sufficient to induce FSGS typi- transgenic, and normal mice. One line of Dgag-pol-nef
transgenic mice (termed X5) was selected for furthercal of HIVAN. The HIV envelope protein gp120, and
the regulatory protein Rev are present within glomeruli study. The experiments reported here were performed
with mice from the X5 line of the F2 and F3 generations.in these mice. Recently, Hanna et al studied a series of
transgenic mice bearing various HIV-1 constructs under In addition, X5 hemizygous mice were mated to HIV-1
nef transgenic mice, whose establishment was previouslythe control of the human CD4 promoter and concluded
that the nef gene is a major determinant of pathogenicity described [14]. Transgenotypes of the progeny of these
pairings (termed NX) were determined by Southernin transgenic mice [13]. Within kidney, transgene expres-
sion was present within the glomerulus and in interstitial blotting genomic DNA digested with BamH1. The X5
and nef transgenes produced bands at 7.4 and 2.9 kb,macrophages. Renal pathology included interstitial ne-
phritis, with tubular atrophy and dilation and interstitial respectively. All mice were cared for in accordance with
National Institutes of Health (NIH) guidelines. Urinarymononuclear infiltrate, but glomerular disease was not
present. protein was measured with a commercial kit (BioRad,
Hercules, CA, USA) using bovine serum albumin as aWe have established Dgag-pol-nef transgenic mice in
order to investigate the role of Nef in HIVAN. Seven standard [15].
independent lines were analyzed, and one was identified
Northern analysison the basis of HIV RNA expression in the kidney.
This line developed FSGS. In situ hybridization studies RNA was prepared by homogenizing kidney in guani-
dine isothiocyanate [16]. Total RNA (40 mg) was electro-demonstrate viral RNA present in glomerular visceral
epithelial cells, tubular epithelial cells, and mononuclear phoresed through a 1% formaldehyde-agarose gel and
transferred to a nylon membrane. cDNAs encoding theinterstitial cells, and HIV-1 envelope protein was present
in a similar distribution. These data suggest the nef gene HIV-1 nef gene [17] or mouse b-actin were 32P-labeled
by the random primer method, hybridized in 50% form-is not required for renal disease and that renal epithelial
cells support LTR-directed transgene expression. The amide at 418C, and washed with 0.1 3 standard saline
citrate (SSC; 15 mmol/L NaCl plus 1.5 mmol/L sodiumextent to which this expression and the renal histopathol-
ogy associated with it are affected by the presence of a citrate) with 0.5% sodium dodecyl sulfate (SDS) at 558C.
Autoradiographic exposures were made at 2708C. Quan-wild-type nef gene was investigated further by crossing
Dgag-pol-nef mice with nef transgenic mice. These dual- titation of RNA levels was determined by phosphorim-
ager analysis (Fuji BAS 2000, Fuji, Japan).transgenic mice had lower renal transgene expression
and less tubular injury compared with Dgag-pol-nef mice.
Histology and immunoperoxidase stainingThese studies suggest that while nef is not required for
the development of FSGS in transgenic mice, nef does Renal tissues were fixed in methanol Carnoy’s solution
(60% methanol, 30% chloroform, and 10% acetic acid)contribute to the regulation of renal transgene expres-
sion and may have additional effects on the evolution overnight at room temperature and were embedded in
paraffin. Sections (5 mm) were stained with the periodicof kidney disease, particularly the appearance of tubulo-
interstitial nephritis. acid-Schiff (PAS) technique or Yajima silver stain. Im-
munoperoxidase staining was performed with a streptav-
idin-biotin complex technique using a Histostain-SP kit
METHODS
(Zymed, Burlingame, CA, USA) according to the in-
Transgenic mice structions of the manufacturer. The primary antibodies
included the following: polyclonal sheep anti–HIV-1Transgenic lines that we have described previously
were made using a noninfectious proviral transgene, in gp120 antiserum, obtained from Dr. M. Phelan through
the AIDS Reference Reagent and Repository Programwhich 3.1 kb of sequence between an SphI site at position
1443 and the BalI site at position 4551 was deleted to (ARRRP) and diluted 1:2000 in phosphate-buffered sa-
line (PBS); control sheep serum, diluted 1:2000 in PBS;generate a gag-pol deleted transgene. One line (termed
T26) has been extensively characterized [11, 12]. The control rabbit IgG, diluted 1:200 in PBS; polyclonal rab-
bit anti-Tat antiserum, obtained from Dr. B. CullenDgag-pol-nef proviral transgene was generated by cutting
at the XhoI site at position 8887, filling with Klenow through the ARRRP and diluted 1:200 in PBS; poly-
clonal rabbit anti-Rev peptide antiserum, diluted 1:200polymerase, in order to generate a premature stop codon
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Fig. 1. Transgene construct. (A) The open
reading frames of HIV-1 are shown, including
the gag genes encoding the viral capsid pro-
teins, the pol genes encoding reverse tran-
scriptase, integrase, and protease, and the env
gene, encoding the envelope proteins gp41
and gp120. The viral regulatory genes include
tat, rev, and nef, and the accessory genes in-
clude vif, vpr, and vpu. The long-terminal re-
peats (LTR) are shown. (B) The gag-pol de-
leted mouse, T26, has a 1.7 kb deletion spanning
all of the gag and most of the pol genes; the
gag-pol-nef–deleted mouse, X5, has this dele-
tion together with a stop codon in nef.
in PBS; polyclonal rabbit anti-Nef antiserum, obtained ffinized three times in xylene and rehydrated in graded
from Dr. B. Cullen through the ARRRP and diluted ethanol. The slides were then incubated in 0.2N HCl for
1:200 in PBS; polyclonal rabbit anti-Vif antiserum ob- five minutes, digested with 1 mg/mL proteinase K for
tained from Dr. B. Cullen through the ARRRP and six minutes, and treated with 0.25% acetic anhydride in
diluted 1:200 in PBS. The secondary antibody was a 0.1 mol/L triethanolamine buffer. After equilibration
biotinylated antibody directed against IgG of the appro- and prehybridization, the slides were hybridized over-
priate species; in the case of primary antibody from night at 508C in a humidified chamber. After washing
sheep, the secondary antibody was directed against goat and ribonuclease treatment, the slides were dipped in
antibody, which was found to detect sheep antibody satis- NTB2 emulsion (Eastman Kodak, Rochester, NY, USA),
factorily. The sections were incubated with streptavidin- exposed for six days over desiccant in the dark, devel-
peroxidase conjugate. Amino ethylcarbazole was used
oped, and counterstained with toluidine blue. The slides
as the peroxidase substrate, and the sections were coun-
were photographed in brightfield and darkfield using aterstained with hematoxylin.
Leica DMR microscope.
In situ hybridization
Apoptosis assayKidney samples from Dgag-pol-nef X5 mice were fixed
Apoptotic cells were analyzed by Trevigen Apoptoticin freshly prepared 4% paraformaldehyde in 0.1 mol/L
Cell System (TACS) in situ kit (Trevigen, Gaithersburg,sodium citrate buffer, pH 7.4, overnight at room temper-
ature. In situ hybridization studies were carried out using MD, USA) according to the instructions of the manufac-
an env-nef-LTR riboprobe generated from the plasmid turer. Double-strand breaks in genomic DNA in tissue
pRG-B [18]. This plasmid contains a 1.35-kb HindIII specimen are detected by enzymatic addition of a biotin-
fragment mapping between 8.25 and 9.6 kb in the LAV ylated nucleotide to free 39 DNA ends with terminal
proviral DNA sequences, spanning from the 39 end of deoxynucleotidyl transferase (TdT). The sections were
env through the nef coding region and LTR region and incubated with streptavidin-peroxidase conjugate, fol-
was obtained from Dr. Howard Gendelman through the lowed by TACS Blue Label used as the peroxidase sub-
ARRRP. The plasmid was digested with SphI, and sense strate, and the sections were counterstained with nuclear35S-labeled riboprobe was transcribed by T7 polymerase fast red.
using MAXIscript kit (Ambion, Austin, TX, USA) ac-
For combined apoptosis assay and in situ hybridiza-cording to the instructions of the manufacturer. For
tion, first, the sections were treated with TdT to incorpo-the transcription of antisense riboprobe, the plasmid
rate biotinylated nucleotide and then hybridized with 35SpRG-B was digested with BamHI and transcribed by SP6
labeled antisense nef riboprobe to detect HIV RNA.polymerase. After the probes were made, each probe was
Next, the sections were incubated with streptavidin-per-sheared by alkaline hydrolysis to yield RNA about 200
oxidase conjugate, followed by diaminobenzidine (DAB)bp in length. In situ hybridization using RNA probes
as the peroxidase substrate. Finally, the sections werewas performed using SureSite In Situ Hybridization Kit
dipped in NTB2 emulsion, exposed for six days, and(Novagen, Madison, WI, USA) according to the instruc-
tions of the manufacturer. Paraffin sections were depara- developed and counterstained with methyl green.
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Fig. 2. The gag-pol deleted mouse, T26, and the gag-pol-nef deleted mouse, X5: Proteinuria and Northern analysis. (A) Urine from normal mice
(s) has ,500 mg/dL protein at all time points in both male (left) and female (right) mice. T26 hemizygotes ( ) and X5 homozygotes (j) exhibit
proteinuria by day 25. X5 hemizygotes (d) exhibit proteinuria later, by day 35. The patterns in males and females were generally similar. Mean 6
SD. (B) Kidney from an X5 homozygote exhibits 7 kb (full length), 4 kb (singly spliced), and 2 kb (doubly spliced) RNA (lane 1). Kidney from
an X5 hemizygote exhibits lower levels of transgene expression (lane 2), and on this exposure, T26 kidney transgene expression is undetectable
(lane 3). All mice were four weeks of age.
Statistics 0.05 by analysis of variance with Bonferonni correction).
In both male and female mice, homozygous X5 mice hadStatistical analysis was performed using Instat soft-
higher levels of proteinuria compared with hemizygousware (GraphPad Software, San Diego, CA, USA) and
X5 mice, consistent with a gene dosage effect (P , 0.05).analysis of variance, with the level of significance chosen
In all transgenic mice, proteinuria began after 20 daysas P , 0.05.
of age and reached a peak at approximately 35 days of
age. By 35 days of age, nearly all X5 mice (45 out of 50)
RESULTS had proteinuria (defined as urine protein .500 mg/dL).
Proteinuria was comparable in males and females.The Dgag-pol-nef transgenic mice described here bear
sequences derived from the infectious clone pNL4-3, Edema developed in 10 of 55 hemizygous X5 mice be-
tween 2 and 10 months of age, and edema developed inwhich has open reading frames in all six regulatory and
accessory genes of HIV-1 (Fig. 1). The presence of the 7 of 8 homozygous X5 mice by 2 months of age. In all
cases, edema was followed within 5 to 10 days by uremicnef mutation in theX5 mice was verified by the inability
to digest 20 independently cloned, PCR-amplified nef death.
We next investigated proviral mRNA expression ingenes with XhoI as described. The failure to express
Nef protein in these mice was demonstrated by Western kidney of 50-day-old X5 mice by Northern analysis, using
a cDNA probe that overlaps with the 39 LTR presentblotting of proteins extracted from skin and muscle (data
not shown), tissues that express Nef at high level in the in all viral RNA and is therefore able to detect all HIV-
1 mRNA species (Fig. 2B). mRNA species of approxi-T26 transgenic mouse [11].
One of seven Dgag-pol-nef HIV-transgenic lines (des- mately 2 and 4 kb, which likely represent singly and
multiply spliced HIV-1 transcripts, respectively, wereignated X5) consistently developed proteinuria between
days 20 and 25 (Fig. 2A). F1 offspring from the remaining seen in the X5 homozygote, as well as small amounts of
full-length 7 kb RNA transcripts. In the X5 hemizygote,six Dgag-pol-nef lines did not express transgene RNA in
kidney at detectable levels nor did they develop renal lesser amounts of 2 kb mRNA were present, although
in greater abundance compared with the T26 mouse. Thedisease. At day 24, protein excretion was significantly
higher in male homozygous Dgag-pol-nef X5 mice com- increased steady-state levels of RNA in the homozygote
compared with the hemizygote are compatible with apared with male wild-type mice, and protein excretion
was significantly higher in female homozygous Dgag-pol- gene dose effect of the transgene. HIV RNA was also
detected in X5 mouse skin and muscle, but no pathologynef X5 mice, hemizygous X5 mice, and hemizygous Dgag-
pol-T26 mice compared with female wild-type mice (P , was detected (data not shown). F1 offspring from the
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Fig. 3. Histopathology stained by PAS. Kidney from a six-week-old normal FVB/N mouse (A, 362; B, 3200). Kidney from a six-week-old X5
hemizygote shows dilated tubules filled with proteinaceous casts and segmental glomerulosclerosis with areas of hyalinosis (C, 362; D, 3200).
Kidney from a six-week-old X5 homozygote shows similar tubular changes and more advanced glomerular changes, with dysplastic changes in the
glomerular epithelial cells (E, 362; F, 3200).
other Dgag-pol-nef mouse lines did not express transgene sis. The increased matrix material stained positively with
both PAS and silver, indicating that the increased extra-RNA and did not develop renal disease (data not shown).
Histologic analysis of the kidneys from hemizygous cellular material indeed represented an accumulation of
extracellular matrix protein. Glomerular synechiae wereand homozygous X5 transgenic mice at six weeks of age
revealed FSGS and microcystic tubular dilation (Fig. 3 frequently seen, but epithelial crescents were absent.
There was diffuse tubular dilation, with tubular epithelialC–F). Glomeruli manifested both focal and global sclero-
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cell attenuation and degeneration. Tubular casts in- ated with less severe renal complications. To investigate
this anomaly further, the temporal relationship betweencluded those that were PAS positive (consistent with the
presence of Tamm-Horsfall protein) and PAS negative HIV gene expression and renal disease was analyzed by
Northern analysis of HIV transcripts relative to animal(consistent with the presence of plasma protein). There
was fibrosis and sparse mononuclear cell infiltration age. As shown in Figure 5A, viral transcripts were recog-
nizable at the onset of renal disease (21 days) and werewithin the interstitial compartment. In general, these
findings parallel quite closely the light microscopic find- still clearly visible at two months of age. The relatively
constant level of expression over this time period con-ings characteristic of patients with HIVAN. These histo-
logic changes were in general more prominent in homo- trasted with the episodic expression of viral mRNA in the
prototype T26 line that developed more severe disease.zygous mice compared with hemizygous mice, as shown
in Figure 3, C and D compared with E and F, consistent The effect of Nef protein on HIV gene expression and
renal disease was explored through a genetic comple-with a gene dose effect. Nevertheless, penetrance of the
renal phenotype was quite high among both groups of mentation strategy using dual-transgenic mice. We bred
Dgag-pol-nef X5 mice with nef transgenic mice. A totalmice. Among homozygous mice, 6 out of 6 showed ab-
normal histopathology, while 10 out of 12 hemizygous of 97 progeny was identified in this study, and 23 were
found to be doubly transgenic (NX mice). Five sex-mice showed disease (2 were normal when tissues were
examined between 1 and 2 months of age). related sibling pairs (NX vs. X5 mice) were analyzed for
kidney-related HIV mRNA expression. Kidney RNAIn situ hybridization using the antisense RNA probe
revealed the expression of proviral mRNA in X5 kidney from a representative X5 and NX mouse are in Figure
5B alongside a Nef-only sibling. No nef mRNA was de-in 100% of glomeruli with greatest intensity at the pe-
riphery of the glomerular capillary tuft (Fig. 4 A–C). This tected in the kidney from nef mice, consistent with previ-
ous observations [14]. Hence, the viral RNA in NX kid-would be consistent with expression by the glomerular
visceral epithelial cell, although parietal epithelial cells neys is likely to reflect only X5-derived transcripts. As
indicated in Figure 5B, viral RNA expression (after nor-and possibly other glomerular cells may also express
viral mRNA. Viral mRNA was also detected in tubular malizing to actin RNA levels) was reduced by half (0.47 6
0.39 for the 5 pairs of mice) in the presence of a functionalepithelial cells and occasional interstitial cells (Fig. 4 C,
D). Homozygous mouse kidney exhibited more intense nef gene compared with the expression in the Dgag-
pol-nef mice. Dgag-pol T26 mice, which also bear a func-RNA signal compared with hemizygous mouse kidney,
in accord with the results of Northern analysis. In situ tional nef gene, had still lower kidney-associated HIV
mRNA levels at 0.09 6 0.04 times that of X5 hemizygoushybridization using the negative control sense RNA
probe showed no specific signal over any of these cell mice (N 5 3, data not shown). Proteinuria was compara-
ble in animals of the X5 and X5/Nef transgenotypestypes (Fig. 4E), and hybridization with the antisense
RNA probe showed no signal in normal kidney (data (Fig. 5C). Long-term studies were not attempted because
many NX mice developed necrotic cutaneous lesionsnot shown).
Using immunoperoxidase staining, we localized enve- warranting their humane sacrifice. Urine protein levels
in nef-only transgenic mice were indistinguishable fromlope protein gp120 within the kidneys of X5 mice. Spe-
cific staining for gp120 was present in over 75% of the nontransgenic mice (data not shown).
Histopathologic analyses were undertaken of kidneyglomeruli from 50-day-old X5 homozygotes and hemizy-
gotes animals. gp120 was consistently and exclusively sections collected from 14 NX mice. These were com-
pared, when possible, to X5 siblings of the same sex.localized to glomerular visceral epithelial cells, particu-
larly to those that appeared hyperplastic (Fig. 4F). gp120 Ages of mice varied between 30 and 90 days. There were
subtle differences between X5 (Dgag-pol-nef) and NXwas also expressed by tubular epithelial cells, chiefly
within the proximal tubules (Fig. 4 G, H). Antibody (nef plus Dgag-pol-nef) mice irrespective of age and sex.
First, segmental glomerulosclerosis was more prevalentdirected against HIV-1 regulatory and accessory proteins
Tat, Rev, Nef, and Vif failed to stain X5 renal tissue in in NX mice both in terms of the fraction of involved
glomeruli and the extent of sclerosis in individual glo-a specific fashion (data not shown).
Some tubular cells that expressed gp120 were dysplas- meruli. Second, tubular alterations were less prevalent
in NX mice, with less microcystic dilation and tubulartic or necrotic (Fig. 4H) or were detached from the tubu-
lar basement membrane. Sloughed tubular epithelial epithelial degeneration. Third, NX mice manifested peri-
vascular infiltrates composed of neutrophils and mono-cells in some cases expressed viral mRNA (Fig. 4D).
On the basis of these analyses, it is apparent that Dgag- nuclear cells (9 out of 14 mice), and while focal infiltrates
of mononuclear cells were observed in 4/8 3 5 mice,pol-nef X5 transgenic mice expressed higher levels of
viral mRNA and protein in renal epithelial cells than did neutrophils were absent.
To assess the mechanism of cellular toxicity in the X5Dgag-pol T26 mice. It was not apparent why transgene
expression was enhanced nor why this would be associ- kidney, we examined the proportion of cells exhibiting
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increased TdT labeling, indicative of free 39 DNA ends present in microdissected renal fragments [19], this may
represent either DNA from lymphocytes or macro-derived from endonuclease activity associated with apo-
phages, within the microcirculation or within the renalptosis (Table 1 and Fig. 6). Kidney from normal mouse
parenchyma, or DNA from intrinsic renal cells. Never-had very few apoptotic cells, located exclusively within
theless, it has been shown that renal cells can supportthe interstitium. We found a marked increase in the
viral replication following infection (glomerular endo-number of apoptotic cells in X5 renal tissue, with the
thelial cells and mesangial cells [5] and tubular epithelialincrease being greater in the homozygote compared with
cells [20, 21]) or transfection (embryonic 293 cells [22]).the hemizygote. The most abundant cells undergoing
Furthermore, HIV-1 proviral DNA sequences can beapoptosis were interstitial cells and tubular epithelial
detected in the urine of the majority of patients infectedcells, particularly sloughed cells within the tubular lu-
with HIV-1 and that HIV-1 RNA can be detected in themen. There were an increased number of glomerular
urine of approximately 5% of seropositive patients [23].cells that labeled with TdT also; these were not confined
None of these patients had evidence of renal disease onto the periphery of the glomerular capillary tuft, as the
urinalysis. The cellular source of these HIV-1 DNA andlocalization for HIV RNA and envelope protein was,
RNA sequences has not been determined; they may de-and instead appeared to represent multiple glomerular
rive from shed renal epithelial cells or from leukocytes.cell types. We then performed TdT labeling and in situ
The findings in the present study confirm and extendhybridization for HIV mRNA on the same tissue section.
our earlier observations that local renal expression ofThis combined technique identified cells expressing HIV
HIV gene products is associated with characteristic renalmRNA (shown within the glomerulus in Fig. 6D) and
pathology. The similar pathology in the Dgag-pol T26apoptotic cells (shown within the tubule in Fig. 6D). Cells
mouse and the Dgag-pol-nef X5 mouse suggests that theexpressing HIV RNA did not appear to be undergoing
nef gene product is not absolutely required for the induc-apoptosis, and cells undergoing apoptosis did not express
tion of FSGS. On the other hand, the discordance thatdetectable amounts of HIV RNA.
exists between levels of HIV gene expression and disease
severity suggests that Nef protein does play some role
DISCUSSION in the progression of FSGS-related renal pathology. In
We have previously described a mouse transgenic for this regard, it is notable that HIV gene expression in
a Dgag-pol HIV-1 genome. Three of eight lines expressed kidney greater in X5 homozygous mice and renal disease
viral RNA in kidney, as assessed by Northern analysis; is comparably more severe compared with hemizygous
all three lines developed FSGS, and one line (T26) has X5 mice, suggesting by this gene dosage effect that more
been characterized in depth [11, 12]. We now describe of a toxic HIV gene product is produced. Since the Dgag-
similar renal histopathology in the X5 mouse, which is pol-nef X5 mice have higher levels of transgene expres-
transgenic for a Dgag-pol-nef HIV-1 genome. HIV-1 en- sion in kidney compared with Dgag-pol T26 mice, it was
velope protein gp120 and HIV-1 mRNA are present expected that the renal disease would have been more
in the glomerular visceral epithelial cells and tubular severe in X5 mice, but this was not the case. Thus, the
epithelial cells in kidneys of homozygous and hemizy- generally similar renal disease in the hemizygous X5
gous X5 mice. These cells are the locus of the major mouse compared with the T26 mouse is indirect but
pathologic changes seen in the kidney, suggesting that suggestive evidence for a contributory role for Nef in
one or more transgene products may be toxic to the producing renal disease.
epithelial cell, which expresses viral products. Further- The model that we propose is that Nef protein both
more, it suggests that renal epithelial cells, at least in down-regulates HIV transcription, reducing renal injury,
the mouse, have a particular capacity to activate LTR- and has an additional role in promoting glomerular in-
directed HIV-1 gene expression. jury. Since Dgag-pol-nef transgenic mice had less trans-
It remains unclear which cells in human kidney may gene expression but glomerular injury comparable to
Dgag-pol transgenic mice, it appears that Nef may serveharbor HIV-1 genetic material. While proviral DNA is
b
Fig. 4. Localization of HIV-1 RNA and protein. In a heterozygous Dgag-pol-nef X5 mouse kidney subjected to in situ hybridization using a
radioactive antisense HIV riboprobe, HIV RNA as visualized with silver grains was present in at the periphery of glomerular capillary tufts (A
362; B 3200). In a homozygous Dgag-pol-nef X5 mouse kidney section hybridized with the antisense HIV riboprobe, HIV RNA was localized
to the periphery of the glomerular capillary tuft, the tubular epithelium, epithelial cells within the tubular lumen, and interstitial cells (arrowheads;
C and D 380). A comparable section hybridized with negative control sense HIV riboprobe showed no signal (E 380). In hemizygous Dgag-pol-
nef X5 mouse kidney, gp120 envelope protein (appearing as red-colored amino ethylcarbazole immunoperoxidase product) was present in glomerular
visceral epithelial cells (F, 3125) and epithelial cells of the proximal tubule (G, 3125), some of which appeared to be sloughing into the tubular
lumen (H, 3125).
Fig. 5. Nef effects on HIV gene expression and pathology in kidney. (A) Northern analysis of transgene expression in Dgag-pol-nef X5 kidneys
at the ages shown, with actin RNA used to demonstrate equality of loading. RNA sizes as determined by an RNA ladder are shown. (B) Northern
analysis of kidney transgene RNA prepared from Nef transgenic mice (N), X5 transgenic mice (X) and Nef/X5 dual hemizygous (NX) transgenic
siblings. (C) Urine protein excretion was assessed in female (left) and male (right) Nef/X5 transgenic mice (s), X5 transgenic mice (solid line)
and nontransgenic mice (d) from the same litters. All groups comprise at least six animals.
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Table 1. Apoptotic cells in X5 transgenic mice described here, there were also no circulating antibodies
to HIV proteins (data not shown). The localization ofTubular
Mouse genotype Glomeruli Tubules Lumen Interstitium gene and protein expression in the present model to
Normal 0.0060.00 0.0060.00 0.0060.00 0.1660.23 the glomerular and tubular epithelium suggests that the
Heterozygotes 0.0860.07 0.5660.32 0.3660.30 0.5860.35 renal epithelium may be conducive to LTR-directed gene
Homozygotes 0.6160.30a 3.6460.62a 4.0161.39a 3.6060.95a
expression, and the toxicity apparent in these cell types
Apoptotic cells were identified by terminal deoxyribonucleotidyl transferase suggests that HIV proteins may have selective toxicity(TdT) labeling assay in kidney tissue from three normal FVB/N mice, four
heterozygous X5 mice, and four homozygous X5 mice, and are expressed as for particular renal cell types. While we present evidence
TdT-positive nuclei per mm2 of tissue area (mean 6 SD). that glomerular and tubular cells exhibit increased apo-a P , 0.01 compared with normal mice.
ptosis, we do not have an understanding of the precise
sequence of molecular events that results in renal pa-
thology.
a facilitating role in amplifying the toxicity of another In the homozygous X5 kidney, an increased number
HIV gene product. Indeed, the complementation studies of cells manifested DNA strand breaks, identified by
presented here further support this possibility. When nef TdT labeling assay, suggested an increased rate of apo-
was bred back on to the Dgag-pol-nef background, there ptotic cell death. The hemizygous X5 kidney showed
was more glomerulosclerosis compared with Dgag-pol- similar pathology but in a milder form, and the number
nef mice, despite lower levels of renal transgene expres- of apoptotic cells did not reach statistical significance
sion. It should be noted that both Nef down-regulation of when compared with the wild-type control mouse. The
HIV gene expression and the ability of Nef to exacerbate increased number of apoptotic cells was most notable in
glomerular disease could be direct or indirect, mediated the tubules and interstitium but was also present in the
by host factors. Hanna et al have reported evidence glomerulus. Since apoptosis is a rapid process and there-
indicating that Nef is responsible for interstitial nephritis fore can only be detected for a brief time, the detection
in HIV-transgenic mice [13]. A possible mechanism for of even a few apoptotic cells in the glomerulus may be
this observation may be the ability of Nef to stimulate of potential pathologic import. HIV-1–infected lympho-
macrophage production of the CC chemokines macro- cytes experience increased rates of apoptosis [27], and
phage inflammatory proteins 1a and 1b [24]. Our data various gene products have been implicated, including
are thus complementary to the findings described for nef gp120 [28] and Tat [29]. Furthermore, kidney tissue from
transgenic mice noted previously in this article: An HIV human patients with HIVAN manifest increased num-
gene (or genes) other than nef is responsible for glomeru- bers of apoptotic cells, suggesting that this form of cell
lar injury and induces interstitial nephritis. death may contribute to the pathogenesis of renal disease
The identity of the HIV gene product or products [30]. The present findings suggest that expression of viral
that induce FSGS remains to be identified. Recently, gene products, acting independently of replicating virus,
glomerulosclerosis has been reported in mice that bear are associated with increased apoptotic cell death. In the
only the six regulatory and accessory genes under the present study, the cells that expressed HIV-1 RNA were
control of the HIV-1 LTR (abstract; Kimmel et al, J not the same cells that were observed to undergo apopto-
Invest Med 44:321A, 1996). Taken together, these find- sis. This may be due apoptotic cells being unable to
ings suggest that one or more regulatory and accessory express HIV-1 RNA, as a consequence of defects in
genes, exclusive of nef, may induce renal disease. Mice cellular metabolism or rapid degradation of RNA; in
that are transgenic for rev and that express the transgene other systems, however, apoptotic cells have been shown
in kidney do not develop renal disease [25]. Similarly, to express increased amounts of particular mRNAs [31].
mice that are transgenic for tat and that express the Alternatively, apoptosis may be an indirect effect of HIV
transgene in kidney do not develop kidney disease [26]. gene expression by neighboring cells, possibly mediated
In both of these transgenic models, expression was not by the release of cytokines or other mediators. Thus, the
under the control of the HIV-1 LTR. It may be that precise role of apoptosis in the renal pathogenesis seen
neither rev nor tat is sufficient to induce renal disease in these mice cannot be determined.
or that the HIV-1 LTR is important for renal pathogene- In summary, focal glomerulosclerosis and tubular dila-
sis in transgenic mice. Untested at present are the acces- tion are seen in transgenic mice bearing a Dgag-pol-
sory proteins Vpr, Vpu, and Vif. nef HIV-1 genome. In the transgenic kidney, envelope
The precise mechanisms by which HIV gene products protein and transgene RNA expression were present in
induce tissue-specific renal pathology remain to be deter- glomerular epithelial cells, tubular epithelial cells, and
mined. In the Dgag-pol T26 transgenic mouse described interstitial cells, and increased numbers of cells were
previously, there were no circulating antibodies to HIV labeled with TdT, indicating apoptosis. These findings
proteins and no evidence of immune complex-mediated indicate that the nef gene is not required for HIVAN in
the mouse but may potentiate renal toxicity. Our findingsrenal disease. In the Dgag-pol-nef X5 transgenic mouse
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Fig. 6. Detection of apoptotic cells using terminal deoxynucleotidyl transferase (TdT) labeling assay. (A) Normal mouse kidney section shows
no apoptotic cells. (B) X5 hemizygous mouse kidney section shows occasional TdT-positive nuclei (blue-black reaction product, arrowhead) within
tubular epithelial cells and interstitial cells. Brown pigment represents hemosiderin-laden macrophages. (C) X5 homozygous mouse kidney section
shows occasional TdT-positive nuclei within tubular epithelial cells and glomerular cells, arrowhead. (D) Colocalization using HIV antisense RNA
(silver grains) and TdT labeling (blue-black reaction product) demonstrates that the cells expressing HIV RNA (in this section, glomerular epithelial
cells, double arrowhead) are not the same cells as those undergoing apoptosis (in this section, tubular epithelial cells, single arrowhead). Counterstain,
A–C, nuclear fast red; D, methyl green. Magnification, A–C, 3100; D, 3120.
Reprint requests to Jeffrey Kopp, M.D., 10/3N116, National Institutesindicate that multiple HIV proteins are likely to contrib-
of Health, Bethesda, MD 20892-1268, USA.
ute to HIVAN in the mouse. E-mail: jbkopp@nih.gov
The high level transgene expression in kidney indi-
cates that this may be a useful model to examine in
NOTE ADDED IN PROOFa quantitative fashion the effect of therapeutic agents
intended to reduce HIV gene expression and tissue in- Dickie P: Nef modulation of HIV type 1 gene expres-
jury. Furthermore, these results have implications for sion and cytopathicity in tissues of HIV transgenic mice.
the development of HIV vaccines incorporating live de- AIDS Res Hum Retrovirus 16:777–790, 2000
fective viruses. HIV proteins have direct pathophysio-
logic actions that occur in the absence of virus replication. REFERENCES
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